Shangping Wu

Shangping Wu

Auto-generated profile, based on publicly available information

Shangping Wu

Department of Endocrinology, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, China, bucm.edu.cn

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 July 2023 in Heliyon
Verified
Journal Article
Open access
XLXiaoyu Liang
Xiaoyu Liang
SWShangping Wu
Shangping Wu
LKLi Ke
Li Ke
HZHaolin Zhang
Haolin Zhang
FYFujing Yang
Fujing Yang
GYGuangyi Yang
Guangyi Yang
This review assessed the effects of reflexology on symptoms in pregnancy. PubMed, Embase, Springer, Web of Science, the Cochrane Library, and reference lists of previous systematic reviews were searched for the eligible randomized controlled trials (RCT) from the inception date of each predefined database up to May 31st, 2023. Data were extracted, and methodological quality was evaluated by the Revised Cochrane risk-of-bias tool for randomized trials (RoB 2). The efficacy of treatment was assessed using pooled effect sizes (Hedges’ g) and 95% confidence intervals (CI). Meta-analysis was performed using the RevMan 5.4 manager, and publication bias was evaluated by Begg's test. The included a total of 13 RCTs in this review, of eleven was high risk of bias and two were low, reported the effects of reflexology on low back and/or pelvic pain (LBPP), labor pain, duration of labor, anxiety, fatigue, sleep quality, constipation symptoms, and ankle and foot edema in pregnancy. The effect sizes (Hedges’ g) for reflexology in labor pain, duration of labor, anxiety, fatigue, and sleep quality showed statistical significance, which the meta-analysis also confirmed except for fatigue and sleep quality due to insufficient studies. Reflexology is probably effective and safe for labor pain, duration of labor, and anxiety in pregnancy, while the evidences for reflexology in LBPP, fatigue, sleep quality, constipation symptoms, and ankle and foot edema during pregnancy were insufficient. Based on the low to high quality of included studies, strong supportive evidence is not yet available. Rigorous-design and large-scale clinical trials should be conducted to provide higher-quality, reliable evidence.

1 January 2026 in Journal of Diabetes Research
Verified
Journal Article
Open access
KQKewen Qu
Kewen Qu
MLMei Li
Mei Li
JSJinxu Sun
Jinxu Sun
SWShangping Wu
Shangping Wu
XLXinyu Liu
Xinyu Liu
XGXiangyu Guo
Xiangyu Guo
Diabetes mellitus (DM) is one of the major chronic diseases endangering human health worldwide, and disorders of hepatic glucose metabolism are its main feature. Glucose homeostasis is maintained by hepatic glycogen synthesis and catabolism, glycolysis, and gluconeogenesis. Inflammation can inhibit glycogen synthesis and cause persistent hyperglycemia via the c‐Jun N‐terminal kinase (JNK) signaling pathway. Shengdihuang Xiyangshen Zhimu Cangzhu (SXZC) formula is a botanical medicine complex with hypoglycemic effects, and it is not clear whether the SXZC formula could improve glucose metabolism in the liver. In this study, we are aimed at investigating the effect of the SXZC formula on hepatic glucose metabolism. The SXZC formula was administered to db/db mice for 4 weeks. Three concentration gradients of the SXZC formula were administered: a high‐dose group (5.96 g·kg −1 ·d −1 ), a medium‐dose group (2.98 g·kg −1 ·d −1 ), and a low‐dose group (1.49 g·kg −1 ·d −1 ). The potential signaling pathways were identified by network pharmacology, subsequently validated via molecular docking and kinetic simulations, as well as molecular experiments. It was found that the SXZC formula reduced blood glucose levels, inflammatory and phosphorylation levels of JNK, c‐Jun, and insulin receptor substrate 1 (IRS1), and promoted glycogen synthase kinase‐3 β (GSK3 β ) phosphorylation and hepatic glycogen synthesis. We indicated that the SXZC formula alleviates hepatic inflammation and promotes hepatic glycogen synthesis by the JNK/c‐Jun/IRS1/GSK3 β signaling pathway.